In Case You Missed It: Multimedia Now Available to Learn More About Light Chain (AL) Amyloidosis and a New Treatment Option

HORSHAM, Pa., Jan. 19, 2021 /PRNewswire/ -- Learn about light chain (AL) amyloidosis and a new treatment option for this rare and serious blood cell disorder.

Experience the interactive Multichannel News Release here: https://www.multivu.com/players/English/8829551-janssen-light-chain-al-amyloidosis/

Media contacts:
Bernadette King
Phone: +1 215-778-3027

Satu Glawe
Phone: +49 172-294-6264

Investor Relations:
Jennifer McIntyre
Phone: +1 732-524-3922

U.S. Medical Inquiries:
+1 800-526-7736

SOURCE Janssen Pharmaceutical Companies of Johnson & Johnson